Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. April 2026 09:16 ET | Quelle: Quantum BioPharma

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of...
22. April 2026 09:00 ET | Quelle: TheRas, Inc. (d/b/a BBOT)

BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman

Pedro J. Beltran, PhD, a seasoned executive who previously served as Chief Scientific Officer of BBOT, will assume the position of Chief Executive Officer, bringing his extensive drug development...
22. April 2026 08:00 ET | Quelle: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Announces Board Chair Transition

PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of...
22. April 2026 07:30 ET | Quelle: BullFrog AI Holdings, Inc.

BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement

GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and...
22. April 2026 07:00 ET | Quelle: Rafael Holdings, Inc.

Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”

NEWARK, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today announced that its subsidiary, Cyclo Therapeutics, has entered into an exclusive licensing agreement with...
22. April 2026 07:00 ET | Quelle: NovaBridge Biosciences

NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value

Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design and business development discussionsStrong industry reputation and...
22. April 2026 06:21 ET | Quelle: Research and Markets

Empty Capsules Market Forecasts Report 2025-2030: Gelatin-based Capsules are Favored for Their Quick Drug Release and Anti-oxidation Properties

Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Empty Capsules Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The Empty Capsules Market is...
22. April 2026 06:00 ET | Quelle: Amneal Pharmaceuticals LLC

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

– Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity – – Transaction Accelerates Growth Profile and Diversification – – Preliminary Q1 Results Reflect...
22. April 2026 05:59 ET | Quelle: Research and Markets

Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca

Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Vulvar Cancer Market - A Global and Regional Analysis: Focus on Cancer Type, End User, Country, and Region, 2025-2035" report has been added to ...
22. April 2026 05:24 ET | Quelle: Research and Markets

Connected Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032: Rising Demand for Telehealth Programs Integrated with AR and Virtual Reality VR Technologies

Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's...

Vorherige Seite

Nächste Seite